{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T03:54:34Z","timestamp":1782446074986,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005615","name":"BETH ISRAEL DEACONESS MEDICAL CENTER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clnu.2024.11.025","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T08:24:27Z","timestamp":1731572667000},"page":"33-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Regulation of proglucagon derived peptides by carbohydrate and protein ingestion in young healthy males\u2013A randomized, double-blind, cross-over trial"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0040-1775","authenticated-orcid":false,"given":"Ioannis","family":"Skarmaliorakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Vasilopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3893-8878","authenticated-orcid":false,"given":"Valeria","family":"Gutierrez de Pi\u00f1eres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2171-7337","authenticated-orcid":false,"given":"Mary","family":"Yannakoulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3536-3034","authenticated-orcid":false,"given":"Costas A.","family":"Anastasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3755-8158","authenticated-orcid":false,"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2024.11.025_bib1","article-title":"The relationship between insulin and glucagon concentrations in non-diabetic humans","volume":"10","author":"Laurenti","year":"2022","journal-title":"Phys Rep"},{"key":"10.1016\/j.clnu.2024.11.025_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/ds19-0076","article-title":"Glucagon therapy: a comparison of current and novel treatments","volume":"33","author":"Sherman","year":"2020","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.clnu.2024.11.025_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155157","article-title":"Methods paper: performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial","volume":"129","author":"Perakakis","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.clnu.2024.11.025_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biom11091281","article-title":"Glucagon as a therapeutic approach to severe hypoglycemia: after 100 Years, is it still the antidote of insulin?","volume":"11","author":"Porcellati","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.clnu.2024.11.025_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metabol"},{"key":"10.1016\/j.clnu.2024.11.025_bib6","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1210\/jc.2015-3885","article-title":"Altered plasma levels of glucagon, GLP-1 and glicentin during OGTT in adolescents with obesity and type 2 diabetes","volume":"101","author":"Manell","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2024.11.025_bib7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41574-018-0016-2","article-title":"Glucagon-like peptide 1 in health and disease","volume":"14","author":"Andersen","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.clnu.2024.11.025_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.970925","article-title":"The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: an in-depth review","volume":"16","author":"Reich","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.clnu.2024.11.025_bib9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jhep.2023.05.013","article-title":"A\u00a0phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease","volume":"79","author":"Romero-G\u00f3mez","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2024.11.025_bib11","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/j.clnu.2022.07.001","article-title":"Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight, overweight, and obesity","volume":"41","author":"Perakakis","year":"2022","journal-title":"Clin Nutr"},{"issue":"Suppl 2","key":"10.1016\/j.clnu.2024.11.025_bib12","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1017\/S0007114512002589","article-title":"Dietary protein - its role in satiety, energetics, weight loss and health","volume":"108","author":"Westerterp-Plantenga","year":"2012","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clnu.2024.11.025_bib13","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3390\/nu10091140","article-title":"Acute and chronic effects of exercise on appetite, energy intake, and appetite-related hormones: the modulating effect of adiposity, sex, and habitual physical activity","volume":"10","author":"Dorling","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2024.11.025_bib14","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1007\/s00421-013-2711-y","article-title":"Meal induced gut hormone secretion is altered in aerobically trained compared to sedentary young healthy males","volume":"113","author":"Lund","year":"2013","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.clnu.2024.11.025_bib15","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/dom.15141","volume":"25","author":"Stefanakis","year":"2023","journal-title":"Diabetes Obes Metabol"},{"issue":"8","key":"10.1016\/j.clnu.2024.11.025_bib46","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.clnu.2023.06.026","article-title":"Circulating levels of all proglucagon-derived peptides are differentially regulated postprandially by obesity status and in response to high-fat meals vs. high-carbohydrate meals","volume":"42","author":"Stefanakis","year":"2023","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2024.11.025_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.689678","article-title":"Proglucagon-derived peptides as therapeutics","volume":"12","author":"Lafferty","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.clnu.2024.11.025_bib17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/B978-0-12-394447-4.10067-7","article-title":"Regulated proteolysis of signaling molecules: the proprotein convertases","author":"Ramos-Molina","year":"2016","journal-title":"Encyclopedia of Cell Biology"},{"key":"10.1016\/j.clnu.2024.11.025_bib18","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/cphy.c200013","article-title":"Glucagon's metabolic action in health and disease","volume":"11","author":"Zeigerer","year":"2021","journal-title":"Compr Physiol"},{"key":"10.1016\/j.clnu.2024.11.025_bib19","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1172\/JCI105916","article-title":"Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids","volume":"47","author":"Ohneda","year":"1968","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clnu.2024.11.025_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/B978-0-12-152825-6.50009-6","article-title":"Characteristics and hormonal regulation of amino acid transport system A in isolated rat hepatocytes","volume":"25","author":"Kilberg","year":"1985","journal-title":"Curr Top Cell Regul"},{"key":"10.1016\/j.clnu.2024.11.025_bib21","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/0026-0495(94)90009-4","article-title":"The role of glucagon in the control of protein and amino acid metabolism in\u00a0vivo","volume":"43","author":"Flakoll","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.clnu.2024.11.025_bib22","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.3390\/nu15183913","article-title":"The regulation and secretion of glucagon in response to nutrient composition: unraveling their intricate mechanisms","volume":"15","author":"Zhang","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2024.11.025_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2337\/db16-0994","article-title":"Glucagon and amino acids are linked in a mutual feedback cycle: the liver-\u03b1-cell Axis","volume":"66","author":"Holst","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.clnu.2024.11.025_bib24","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1016\/j.clnu.2021.01.020","article-title":"Branched-Chain Amino Acids in relation to food preferences and insulin resistance in obese subjects consuming walnuts: a cross-over, randomized, double-blind, placebo-controlled inpatient physiology study","volume":"40","author":"Tuccinardi","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2024.11.025_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0014-5793(81)80772-7","article-title":"The major proglucagon fragment: an abundant islet protein and secretory product","volume":"129","author":"Patzelt","year":"1981","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clnu.2024.11.025_bib25","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1210\/clinem\/dgz172","article-title":"Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD","volume":"105","author":"Polyzos","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2024.11.025_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI115012","article-title":"Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine","volume":"87","author":"Orskov","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clnu.2024.11.025_bib27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1210\/en.2004-1118","article-title":"Significance of prohormone convertase 2, PC2, mediated initial cleavage at the proglucagon interdomain site, Lys70-Arg71, to generate glucagon","volume":"146","author":"Dey","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.clnu.2024.11.025_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1677\/joe.0.1380159","article-title":"Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns","volume":"138","author":"Elliott","year":"1993","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.clnu.2024.11.025_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3945\/ajcn.2008.26362","article-title":"Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects","volume":"89","author":"Greenfield","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2024.11.025_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000201231","article-title":"Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients","volume":"56","author":"Herrmann","year":"1995","journal-title":"Digestion"},{"key":"10.1016\/j.clnu.2024.11.025_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3406","article-title":"The Mediterranean diet increases glucagon-like peptide 1 and oxyntomodulin compared with a vegetarian diet in patients with type 2 diabetes: a randomized controlled cross-over trial","volume":"37","author":"Di Mauro","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.clnu.2024.11.025_bib32","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1093\/advances\/nmab078","article-title":"Protein- and calcium-mediated GLP-1 secretion: a narrative review","volume":"12","author":"Watkins","year":"2021","journal-title":"Adv Nutr"},{"key":"10.1016\/j.clnu.2024.11.025_bib33","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1210\/jc.2015-2335","article-title":"Effect of oxyntomodulin, glucagon, GLP-1, and combined glucagon\u00a0+GLP-1 infusion on food intake, appetite, and resting energy expenditure","volume":"100","author":"Bagger","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2024.11.025_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12050420","article-title":"The sensory mechanisms of nutrient-induced GLP-1 secretion","volume":"12","author":"Hj\u00f8rne","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.clnu.2024.11.025_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ajcn\/83.1.89","article-title":"Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber","volume":"83","author":"Lejeune","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2024.11.025_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/ajcn\/77.1.91","article-title":"Meals with similar energy densities but rich in protein, fat, carbohydrate, or alcohol have different effects on energy expenditure and substrate metabolism but not on appetite and energy intake","volume":"77","author":"Raben","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2024.11.025_bib37","first-page":"989","article-title":"Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin","volume":"7","author":"Capuano","year":"2013","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.clnu.2024.11.025_bib38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/bjs.5227","article-title":"Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety","volume":"93","author":"Borg","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.clnu.2024.11.025_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12986-016-0153-3","article-title":"Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review","volume":"13","author":"Bodnaruc","year":"2016","journal-title":"Nutr Metab"},{"key":"10.1016\/j.clnu.2024.11.025_bib47","doi-asserted-by":"crossref","first-page":"155773","DOI":"10.1016\/j.metabol.2023.155773","article-title":"Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A longitudinal and a case-control study","volume":"152","author":"Kokkinos","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.clnu.2024.11.025_bib40","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa061","article-title":"Oxyntomodulin and glicentin may predict the effect of bariatric surgery on food preferences and weight loss","volume":"105","author":"Nielsen","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2024.11.025_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.153997","article-title":"Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: evidence from two independent trials","volume":"101","author":"Perakakis","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.clnu.2024.11.025_bib42","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa329","article-title":"The role of glicentin and oxyntomodulin in human metabolism: new evidence and new directions","volume":"105","author":"Perakakis","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2024.11.025_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1389203723666220217142935","article-title":"Glucagon-like peptide-2 in the control of gastrointestinal motility: physiological implications","volume":"23","author":"Baccari","year":"2022","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.clnu.2024.11.025_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0016-5085(99)70555-X","article-title":"Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans","volume":"117","author":"Xiao","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2024.11.025_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.physbeh.2011.12.001","article-title":"Nutrient detection by incretin hormone secreting cells","volume":"106","author":"Diakogiannaki","year":"2012","journal-title":"Physiol Behav"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424004229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424004229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T23:40:09Z","timestamp":1736206809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561424004229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":47,"alternative-id":["S0261561424004229"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2024.11.025","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of proglucagon derived peptides by carbohydrate and protein ingestion in young healthy males\u2013A randomized, double-blind, cross-over trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2024.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}